Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: A randomized controlled trial

Obstetrics and Gynecology

Volumn 116, Issue 3, 2010, Pages 612-618

  Ho, Ming ^a   Cheng, Shi Yann ^a   Li, Tsai Chung ^b  

^a CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; OXYTOCIN; OXYTOCIC AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DOSE TITRATION; DRUG HALF LIFE; FEMALE; FEVER; GESTATIONAL AGE; HUMAN; HUMAN EXPERIMENT; LABOR INDUCTION; LABOR STAGE 1; MAXIMUM PLASMA CONCENTRATION; NAUSEA; NEWBORN CARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; SHIVERING; TIME TO MAXIMUM PLASMA CONCENTRATION; UTERINE CERVIX DILATATION; UTERINE CERVIX RIPENING; UTERUS CONTRACTION; VAGINAL DELIVERY; VOMITING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; ORAL DRUG ADMINISTRATION; PREGNANCY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LABOR, INDUCED; MISOPROSTOL; OXYTOCICS; OXYTOCIN; PREGNANCY; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77957287601     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181ed36cc     Document Type: Article

References (29)

1. Waldenström U, Hildingsson I, Rubertsson C, Rådestad I. A negative birth experience: prevalence and risk factors in a national sample. Birth 2004;31:17-27.
2. Nystedt A, Högberg U, Lundman B. Some Swedish women's experiences of prolonged labour. Midwifery 2006;22:56-65.
3. Florica M, Stephansson O, Nordström L. Indications associ-ated with increased cesarean section rates in a Swedish hospi-tal. Int J Gynaecol Obstet 2006;92:181-5.
4. Bugg GJ, Stanley E, Baker PN, Taggart MJ, Johnston TA. Outcomes of labours augmented with oxytocin. Eur J Obstet Gynecol Reprod Biol 2006;124:37-41.
5. McNiven PS, Williams JI, Hodnett E, Kaufman K, Hannah ME. An early labor assessment program: a randomized, con-trolled trial. Birth 1998;25:5-10.
6. Lederman RP, Lederman E, Work BA Jr, McCann DS. The relationship of maternal anxiety, plasma catecholamines, and plasma cortisol to progress in labor. Am J Obstet Gynecol 1978;132:495-500.
7. Selin L, Wallin G, Berg M. Dystocia in labour-risk factors, management and outcome: a retrospective observational study in a Swedish setting. Acta Obstet Gynecol Scand 2008;87: 216-21.
8. New U.S. Food and Drug Administration labeling on Cytotec (misoprostol) use and pregnancy. ACOG Committee Opinion No. 283. American College of Obstetricians and Gynecologists. Obstet Gynecol 2003;101:1049-50.
9. Margulies M, Campos Pérez G, Voto LS. Misoprostol to induce labour. Lancet 1992;339:64.
10. Sanchez-Ramos L, Kaunitz AM, Del Valle GO, Delke I, Schroeder PA, Briones DK. Labor induction with the prosta-glandin E1 methyl analogue misoprostol versus oxytocin: a randomized trial. Obstet Gynecol 1993;81:332-6.
11. Hofmeyr GJ, Gülmezoglu AM, Alfirevic Z. Misoprostol for induction of labour: asystematic review. Br J Obstet Gynaecol 1999;106:798-803.
12. Wing DA. Labor induction with misoprostol. Am J Obstet Gynecol 1999;181:339-45.
13. Keirse MJ. Prostaglandins in preinduction cervical ripening. Meta-analysis of worldwide clinical experience.J Reprod Med 1993;38(1 suppl):89-100.
14. Alfirevic Z, Weeks A. Oral misoprostol for induction of labour. The Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD001338. DOI: 10.1002/14651858.CD001338.pub2.
15. Bennett KA, Butt K, Crane JM, Hutchens D, Young DC A masked randomized comparison of oral and vaginal adminis-tration of misoprostol for labor induction. Obstet Gynecol 1998;92:481-6.
16. Hofmeyr GJ, Gülmezoglu AM. Vaginal misoprostol for cervi-cal ripening and induction of labour. The Cochrane Database of Systematic Reviews 2001, Issue 1. Art. No.: CD000941. DOI: 10.1002/14651858.CD000941.
17. Kolderup L, McLean L, Grullon K, Safford K, Kilpatrick SJ. Misoprostol is more efficacious for labor induction than pros-taglandin E2, but is it associated with more risk? Am J Obstet Gynecol 1999;180:1543-50.
18. Shetty A, Danielian P, Templeton A. A comparison of oral and vaginal misoprostol tablets in induction of labour at term. BJOG 2001;108:238-43.
19. Shetty A, Danielian P, Templeton A. Sublingual misoprostol for the induction of labor at term. Am J Obstet Gynecol 2002;186:72-6.
20. Shetty A, Martin R, Danielian P, Templeton A. A comparison of two dosage regimens of oral misoprostol for labor induction at term. Acta Obstet Gynecol Scand 2002;81:337-42.
21. Wing DA, Park MR, Paul RH. A randomized comparison of oral and intravaginal misoprostol for labor induction. Obstet Gynecol 2000;95:905-8.
22. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal admin-istration. Obstet Gynecol 1997;90:88-92.
23. Cheng SY, Chen TC. Pilot study of labor induction with titrated oral misoprostol. Taiwan J Obstet Gynecol 2006;45: 225-9.
24. Cheng SY, Ming H, Lee JC. Titrated oral compared with vaginal misoprostol for labor induction: a randomized con-trolled trial. Obstet Gynecol 2008;111:119-25.
25. Sweha A, Hacker TW, Nuovo J. Interpretation of the elec-tronic fetal heart rate during labor. Am Fam Physician 1999; 59:2487-500.
26. Betrán AP, Merialdi M, Lauer JA, Bing-Shun W, Thomas J, Van Look P, et al. Rates of caesarean section: analysis of global, regional and national estimates. Paediatr Perinat Epi-demiol 2007;21:98-113.
27. O'Driscoll K, Foley M, MacDonald D. Active management of labor as an alternative to cesarean section for dystocia Obstet Gynecol 1984;63:485-90.
28. Jamal A, Kalantari R. High and low dose oxytocin in augmen-tation of labor. Int J Gynaecol Obstet 2004;87:6-8.
29. Wing DA, Fassett MJ, Guberman C, Tran S, Parrish A, Guinn D. A comparison of orally administered misoprostol to intravenous oxytocin for labor induction in women with favorable cervical examinations. Am J Obstet Gynecol 2004;190:1689-94.